Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: OldBoar	10/29/2015 7:17:15 AM
	Read Replies (1) of 2026

Gang, Opinions? APRI has US rights to Vitaros from Allergan, with an option. Now, Pfizer merges with/acquires Allergan. (see below) Does anyone else see this as HUGE? I.e. Pfizer runs with Topical Viagra in US. Sales in Europe increase due to US advertising. Cash issues go away. Institutional investors jump on board.............. I know I might be "out there" with sequence of events. But, this pathway , or acquisition could be biggest step yet. Opinions? Old Boar "Allergan (NYSE: AGN) is up 15% premarket on light volume on the news that it is in talks with Pfizer (NYSE: PFE) about a possible merger. If the deal goes through, it would create the world's largest healthcare firm with a market value of $330B, larger than Johnson & Johnson's (NYSE: JNJ) market cap of $278B."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next